Multicenter, randomized, parallel-group study of the safety and effectiveness of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/mL smooth, cohesive gel) alone and in combination for lower facial rejuvenation

Dermatologic Surgery

Volumn 36, Issue SUPPL. 4, 2010, Pages 2121-2134

  Carruthers, Alastair ^a   Carruthers, Jean ^a   Monheit, Gary D ^b   Davis, Paula G ^c   Tardie, Greg ^c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c Health Learning Systems   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; HYALURONIC ACID;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; FACE; FEMALE; HUMAN; HUMAN EXPERIMENT; MULTICENTER STUDY; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REJUVENATION; SINGLE BLIND PROCEDURE; SKIN CARE;

ADULT; BIOCOMPATIBLE MATERIALS; BOTULINUM TOXINS, TYPE A; COSMETIC TECHNIQUES; DRUG THERAPY, COMBINATION; FACE; FEMALE; GELS; HUMANS; HYALURONIC ACID; INJECTIONS; MIDDLE AGED; NEUROMUSCULAR AGENTS; PROSPECTIVE STUDIES; REJUVENATION; SKIN AGING; TREATMENT OUTCOME;

EID: 78650143845     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2010.01705.x     Document Type: Article

References (24)

1. Honigman R, Castle DJ., Aging and cosmetic enhancement. Clin Interv Aging 2006; 1: 115-9.
2. Tan SR, Glogau RG., Filler esthetics. In:, Carruthers A, Carruthers J, editors. Procedures in cosmetic dermatology series: soft tissue augmentation. Philadelphia, PA: WB Saunders Company; 2005. p. 8-13.
3. Demas PN, Braun TW., Esthetic facial surgery for women. Dent Clin North Am 2001; 45: 555-69.
4. Sarnoff DS, Saini R, Gotkin RH., Comparison of filling agents for lip augmentation. Aesthet Surg J 2008; 28: 556-63.
5. Sclafani AP., Soft tissue fillers for management of the aging perioral complex. Facial Plast Surg 2005; 21: 74-8.
6. Mandy S., Art of the lip. Dermatol Surg 2007; 33: 521-2.
7. Klein AW., In search of the perfect lip: 2005. Dermatol Surg 2005; 31: 1599-603.
8. Heckmann M, Teichmann B, Schroder U, et al,. Pharmacologic denervation of frown muscles enhances baseline expression of happiness and decreases baseline expression of anger, sadness, and fear. J Am Acad Dermatol 2003; 49: 213-6.
9. Finzi E, Wasserman E., Treatment of depression with botulinum toxin A: a case series. Dermatol Surg 2006; 32: 645-9.
10. Lewis MB, Bowler PJ., Botulinum toxin cosmetic therapy correlates with a more positive mood. J Cosmet Dermatol 2009; 8: 24-6.
11. Dayan SH, Lieberman ED, Thakkar NN, et al,. Botulinum toxin A can positively impact first impression. Dermatol Surg 2008; 34: S40-7.
12. Carruthers JDA, Glogau RG, Blitzer A., Advances in facial rejuvenation: botulinum toxin type A, hyaluronic acid dermal fillers, and combination therapies-consensus recommendations. Plast Reconstr Surg 2008; 121 (suppl 5): 5S-30S.
13. Lewis CD, Perry JD., A paradigm shift: volume augmentation or 'inflation' to obtain optimal cosmetic results. Curr Opin Ophthalmol 2009; 20: 389-94.
14. Donath AS, Glasgold RA, Glasgold MJ., Volume loss versus gravity: new concepts in facial aging. Curr Opin Otolaryngol Head Neck Surg 2007; 15: 238-43.
15. Carruthers A, Carruthers J, Lowe NJ, et al,. One-year, randomised, multicenter, two-period study of the safety and efficacy of repeated treatments with botulinum toxin type A in patients with glabellar lines. J Clin Res 2004; 7: 1-20.
16. Harii K, Kawashima M., A double-blind, randomized, placebo-controlled, two-dose comparative study of botulinum toxin type A for treating glabellar lines in Japanese subjects. Aesthetic Plast Surg 2008; 32: 724-30.
17. Brandt F, Swanson N, Baumann L, et al,. Randomized, placebo-controlled study of a new botulinum toxin type A for treatment of glabellar lines: efficacy and safety. Dermatol Surg 2009; 35: 1893-901.
18. Carruthers A, Carruthers J., Prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in men with glabellar rhytids. Dermatol Surg 2005; 31: 1297-303.
19. Grimes PE, Shabazz D., A four-month randomized, double-blind evaluation of the efficacy of botulinum toxin type A for the treatment of glabellar lines in women with skin types V and VI. Dermatol Surg 2009; 35: 429-35.
20. Carruthers J, Carruthers A., A prospective, randomized, parallel group study analyzing the effect of BTX-A (Botox) and nonanimal sourced hyaluronic acid (NASHA, Restylane) in combination compared with NASHA (Restylane) alone in severe glabellar rhytides in adult female subjects: treatment of severe glabellar rhytides with a hyaluronic acid derivative compared with the derivative and BTX-A. Dermatol Surg 2003; 29: 802-9.
21. Coleman KR, Carruthers J., Combination therapy with BOTOX and fillers: the new rejuvenation paradigm. Dermatol Ther 2006; 19: 177-88.
22. Lupo MP, Smith SR, Thomas JA, et al,. Effectiveness of Juvéderm Ultra Plus dermal filler in the treatment of severe nasolabial folds. Plast Reconstr Surg 2008; 121: 289-97.
23. Pinsky MA, Thomas JA, Murphy DK, et al,. Juvéderm injectable gel: a multicenter, double-blind, randomized study of safety and effectiveness. Aesthetic Surg J 2008; 28: 17-23.
24. Carruthers J, Carruthers A, Monheit GD., Multicenter, randomized parallel group study of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/mL smooth, cohesive gel) alone and in combination for lower facial rejuvenation: satisfaction and patient-reported outcomes. Dermatol Surg 2010; 36 (Suppl 4): 2121-34.